TrialBone marrow transplantation2019

Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome.

Thierry Guillaume et al.PubMed ↗Publisher ↗

No numbers read from the abstract.